Cargando…

Sars-CoV2 pandemic and lockdown reported consequences on people with multiple sclerosis

Detalles Bibliográficos
Autores principales:	Sartori, Arianna, Dinoto, Alessandro, Pasquin, Fulvio, Baldini, Sara, Bratina, Alessio, Bosco, Antonio, Manganotti, Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498476/ http://dx.doi.org/10.1016/j.jns.2021.119831

Ejemplares similares

Telemedicine for routinary multiple sclerosis follow-up during SARS-CoV2 pandemic: A single center experience
por: Sartori, Arianna, et al.
Publicado: (2021)

Microstates in multiple sclerosis: an electrophysiological signature of altered large-scale networks functioning?
por: Baldini, Sara, et al.
Publicado: (2022)

Telemedicine during the SARS-COV-2 pandemic lockdown: Monitoring stress and quality of sleep in patients with epilepsy
por: Olivo, Sasha, et al.
Publicado: (2021)

Comment on “Anti-NMDA receptor encephalitis presenting as new onset refractory status epilepticus in COVID-19”
por: Dinoto, Alessandro, et al.
Publicado: (2020)

Telemedicine during the SARS-Cov-2 pandemic lockdown: Monitoring stress and quality of sleep in patients with epilepsy
por: Olivo, S., et al.
Publicado: (2021)

COVID-19 lockdown attack on headache emergency admissions: a multidisciplinary retrospective study
por: D’Acunto, Laura, et al.
Publicado: (2021)

Emergency department attendances for seizures: The SARS-COV-2 pandemic impact
por: Cheli, Marta, et al.
Publicado: (2021)

SARS-CoV-2 pandemic and epilepsy: The impact on emergency department attendances for seizures
por: Cheli, Marta, et al.
Publicado: (2020)

Challenges in the Diagnosis and Treatment of Neuromyelitis Optica Spectrum Disorders: A Case Report With a Brief Review of Literature
por: Morelli, Maria Elisa, et al.
Publicado: (2018)

Treatment of Fatigue in Multiple Sclerosis Patients: A Neurocognitive Approach
por: Catalan, Mauro, et al.
Publicado: (2011)

Risk of disease relapse following COVID-19 vaccination in patients with AQP4-IgG-positive NMOSD and MOGAD
por: Dinoto, Alessandro, et al.
Publicado: (2022)

Migraine and COVID-19 lockdown
por: D'Acunto, Laura, et al.
Publicado: (2021)

Is there a correlation between MOG‐associated disorder and SARS‐CoV‐2 infection?
por: Mariotto, Sara, et al.
Publicado: (2022)

THE CONSEQUENCES OF THE LOCKDOWN ON CARDIOVASCULAR DISEASES
por: Aajal, Assia, et al.
Publicado: (2021)

Glycaemic Control Among People with Type 1 Diabetes During Lockdown for the SARS-CoV-2 Outbreak in Italy
por: Bonora, Benedetta Maria, et al.
Publicado: (2020)

Going through the lockdown: a longitudinal study on the psychological consequences of the coronavirus pandemic
por: Gullo, Salvatore, et al.
Publicado: (2021)

The impact of lockdown during SARS-CoV-2 outbreak on behavioral and psychological symptoms of dementia
por: Manini, Arianna, et al.
Publicado: (2021)

COVID-19 pandemic and lockdown stress consequences in people with and without Irritable Bowel Syndrome
por: Sabate, J.-M., et al.
Publicado: (2021)

Efectividad y seguridad de las vacunas para el SARS-CoV-2 actualmente disponibles
por: Marco, José Javier Gómez, et al.
Publicado: (2021)

Biopsychosocial Response to the COVID-19 Lockdown in People with Major Depressive Disorder and Multiple Sclerosis
por: Siddi, Sara, et al.
Publicado: (2022)

Multifocal nivolumab immune-related adverse effects during asymptomatic SARS-CoV-2 infection: causality or casuality?
por: Dinoto, Alessandro, et al.
Publicado: (2022)

Consequences of COVID19-pandemic lockdown on Italian occupational physicians’ psychosocial health
por: De Sio, Simone, et al.
Publicado: (2021)

Psychological consequences of COVID-19 pandemic on people with multiple sclerosis: A meta-analytic study
por: Altieri, Manuela, et al.
Publicado: (2021)

Social and professional consequences of COVID-19 lockdown in patients with multiple sclerosis from 2 very different populations
por: Zhang, G.-X., et al.
Publicado: (2021)

Beyond Lockdown: The Potential Side Effects of the SARS-CoV-2 Pandemic on Public Health
por: Paltrinieri, Sara, et al.
Publicado: (2021)

Persistence of Lockdown Consequences on Children: A Cross-sectional Comparative Study
por: Picca, Marina, et al.
Publicado: (2022)

CN29 SARS-CoV-2 and the perspectives of people living with cancer: The AIIAO survey on the Italian lockdown
por: Biagioli, V., et al.
Publicado: (2020)

The Consequences of the COVID-19 Lockdown on Stalking Victimisation
por: Bracewell, Kelly, et al.
Publicado: (2020)

SARS-CoV-2 vaccines tolerability: A perspective by people with multiple sclerosis
por: Di Filippo, Massimiliano, et al.
Publicado: (2022)

Pulse immunosuppressive therapy for multiple sclerosis during the SARS-CoV-2 lockdown de-escalation plan: safety algorithm()
por: Valero-López, G., et al.
Publicado: (2020)

Miller Fisher syndrome diagnosis and treatment in a patient with SARS-CoV-2
por: Manganotti, Paolo, et al.
Publicado: (2020)

Effects of a reorganization of cirrhosis care during the lockdown for SARS-CoV-2 outbreak
por: Piano, Salvatore, et al.
Publicado: (2021)

Household transmissions of SARS-CoV-2 in the time of unprecedented travel lockdown in China
por: Xu, Xiao-Ke, et al.
Publicado: (2020)

Neutralizing antibody responses against SARS-CoV-2 in vaccinated people with multiple sclerosis
por: Gyang, Tirisham V., et al.
Publicado: (2022)

Safety profile of SARS-CoV-2 vaccination in patients with antibody-mediated CNS disorders
por: Dinoto, Alessandro, et al.
Publicado: (2022)

(123)I‐Metaiodobenzylguanidine Myocardial Scintigraphy in Discriminating Degenerative Parkinsonisms
por: Catalan, Mauro, et al.
Publicado: (2021)

Sleep-Disordered Breathing in People with Multiple Sclerosis: Prevalence, Pathophysiological Mechanisms, and Disease Consequences
por: Hensen, Hanna A., et al.
Publicado: (2018)

Consequences of COVID-19 Lockdown on the Misuse and Marketing of Addictive Substances and New Psychoactive Substances
por: Di Trana, Annagiulia, et al.
Publicado: (2020)

Treatment Options in Refractory Autoimmune Encephalitis
por: Dinoto, Alessandro, et al.
Publicado: (2022)

Papel protector de las actuales vacunas para las variantes del virus SARS-CoV-2 y la COVID persistente
por: Marco, José Javier Gómez, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0s3luf19dopj90koe8j88d643t